• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

统计和图形方法在药物警戒中用于自发报告不良事件的不适当性分析。

Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance.

机构信息

SAS Institute, Inc., Cary, North Carolina, USA.

出版信息

Chin J Nat Med. 2013 May;11(3):314-20. doi: 10.1016/S1875-5364(13)60035-7.

DOI:10.1016/S1875-5364(13)60035-7
PMID:23725848
Abstract

AIM

Combine disproportionality analysis with dynamically interactive graphics to understand spontaneously-reported adverse events in pharmacovigilance.

METHODS

Four statistical methods, including Reporting Odds Ratio, Proportional Reporting Ratio, Multi-Item Gamma Poisson Shrinker and Bayesian Confidence Propagation Neural Network that are used for computing disproportionality are described. Tree maps and other graphical techniques are used to display the disproportionality results.

RESULTS

Spontaneously-reported adverse events in pharmacovigilance are collected from physicians, patients, or the medical literature by regulatory agencies, pharmaceutical companies and device manufacturers to monitor the safety of a product once it reaches the market. In order to identify potential safety-signals, disproportionality analysis methods compare the rate at which a particular event of interest co-occurs with a given drug with the rate this event occurs without the drug in the event database. Tree maps are employed to interactively display the adverse events for particular drugs and compare the adverse events among the drugs.

CONCLUSION

Interactive graphical displays of disproportionality allow the analyst to quickly identify safety signals and perform additional follow-up analyses. Combining statistical methods with dynamically interactive graphics affords insights into the data inaccessible by traditional analysis methods.

摘要

目的

将不均衡分析与动态交互式图形相结合,以了解药物警戒中自发报告的不良事件。

方法

描述了四种用于计算不均衡性的统计方法,包括报告比值比、比例报告比值、多项目伽马泊松收缩器和贝叶斯置信传播神经网络。树图和其他图形技术用于显示不均衡性结果。

结果

药物警戒中的自发报告不良事件由监管机构、制药公司和设备制造商从医生、患者或医学文献中收集,以在产品上市后监测其安全性。为了识别潜在的安全信号,不均衡性分析方法将特定感兴趣事件与特定药物同时发生的速率与该事件在事件数据库中无药物时发生的速率进行比较。树图用于交互式显示特定药物的不良事件,并比较药物之间的不良事件。

结论

不均衡性的交互式图形显示使分析师能够快速识别安全信号并进行额外的后续分析。将统计方法与动态交互式图形相结合,可以深入了解传统分析方法无法获取的数据。

相似文献

1
Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance.统计和图形方法在药物警戒中用于自发报告不良事件的不适当性分析。
Chin J Nat Med. 2013 May;11(3):314-20. doi: 10.1016/S1875-5364(13)60035-7.
2
Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.两种定量安全信号方法的比较性能:对药物警戒部门使用的启示
Drug Saf. 2006;29(10):875-87. doi: 10.2165/00002018-200629100-00005.
3
Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).抗精神病药物、血糖紊乱与危及生命的糖尿病事件:对美国食品药品监督管理局不良事件报告系统(1968 - 2004年)的贝叶斯数据挖掘分析
Ann Clin Psychiatry. 2008 Jan-Mar;20(1):21-31. doi: 10.1080/10401230701844612.
4
Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System.基于美国食品药品监督管理局医疗器械报告系统的植入式心脏复律除颤器相关不良事件信号检测的不均衡性分析。
Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):87-93. doi: 10.1002/pds.2261. Epub 2011 Nov 18.
5
A conceptual approach to the masking effect of measures of disproportionality.不均衡性测量的掩盖效应的概念性方法。
Pharmacoepidemiol Drug Saf. 2014 Feb;23(2):208-17. doi: 10.1002/pds.3530. Epub 2013 Nov 15.
6
Exploration of statistical shrinkage parameters of disproportionality methods in spontaneous reporting system of China.中国自发呈报系统中不成比例法统计收缩参数的探索
Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):962-70. doi: 10.1002/pds.3811. Epub 2015 Jun 11.
7
Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.曲坦类药物与严重不良血管事件:FDA 不良事件报告系统数据库的数据挖掘。
Cephalalgia. 2014 Jan;34(1):5-13. doi: 10.1177/0333102413499649. Epub 2013 Aug 6.
8
Quantitative methods in pharmacovigilance: focus on signal detection.药物警戒中的定量方法:聚焦信号检测
Drug Saf. 2003;26(3):159-86. doi: 10.2165/00002018-200326030-00003.
9
Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and Multi-item Gamma Poisson Shrinker.所有的定量药物上市后信号检测方法都一样吗?逻辑回归和多项目伽马泊松收缩器的性能特征。
Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):622-30. doi: 10.1002/pds.2247. Epub 2011 Oct 12.
10
Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases.评估不均衡性分析的掩盖效应在两个自发报告系统数据库中的程度及影响。
Pharmacoepidemiol Drug Saf. 2014 Feb;23(2):195-207. doi: 10.1002/pds.3529. Epub 2013 Nov 15.

引用本文的文献

1
Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system.评估偏头痛治疗与耳鸣之间的关联:来自美国食品药品监督管理局不良事件报告系统的见解。
PLoS One. 2025 Aug 20;20(8):e0330493. doi: 10.1371/journal.pone.0330493. eCollection 2025.
2
Comparison of Adverse Events in Pregnant Persons Receiving COVID-19 and Influenza Vaccines: A Disproportionality Analysis Using Combined Data from US VAERS and EudraVigilance Spontaneous Report Databases.接种新冠疫苗与流感疫苗的孕妇不良事件比较:一项使用美国疫苗不良事件报告系统(VAERS)和欧洲药物警戒自发报告数据库综合数据的不成比例分析
Drug Saf. 2025 Jun 10. doi: 10.1007/s40264-025-01561-6.
3
A real-world disproportionality analysis of ripretinib data mining of the public version of FDA adverse event reporting system.
对美国食品药品监督管理局不良事件报告系统公开版本中瑞派替尼数据挖掘的真实世界不均衡性分析。
Front Pharmacol. 2025 Mar 18;16:1469597. doi: 10.3389/fphar.2025.1469597. eCollection 2025.
4
Neurological Adverse Events Associated with the Use of Janus Kinase Inhibitors: A Pharmacovigilance Study Based on Vigibase.与使用 Janus 激酶抑制剂相关的神经系统不良事件:一项基于 Vigibase 的药物警戒研究。
Pharmaceuticals (Basel). 2025 Mar 11;18(3):394. doi: 10.3390/ph18030394.
5
A real-world disproportionality analysis of the US Food and Drug Administration (FDA) adverse event reporting system (FAERS) events for Durvalumab.一项针对度伐利尤单抗的美国食品药品监督管理局(FDA)不良事件报告系统(FAERS)事件的真实世界不均衡性分析。
BMC Pharmacol Toxicol. 2024 Dec 18;25(1):97. doi: 10.1186/s40360-024-00821-y.
6
Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS.胺碘酮与决奈达隆的药物不良反应信号挖掘比较:一项基于美国食品药品监督管理局不良事件报告系统的药物警戒研究
Front Pharmacol. 2024 Oct 22;15:1438292. doi: 10.3389/fphar.2024.1438292. eCollection 2024.
7
A real-world disproportionality analysis of Everolimus: data mining of the public version of FDA adverse event reporting system.依维莫司的真实世界不均衡性分析:美国食品药品监督管理局不良事件报告系统公开版本的数据挖掘
Front Pharmacol. 2024 Mar 12;15:1333662. doi: 10.3389/fphar.2024.1333662. eCollection 2024.
8
Navigating the complex landscape of benzodiazepine- and Z-drug diversity: insights from comprehensive FDA adverse event reporting system analysis and beyond.探索苯二氮䓬类药物和Z类药物多样性的复杂局面:来自美国食品药品监督管理局全面不良事件报告系统分析及其他方面的见解
Front Psychiatry. 2023 Jun 23;14:1188101. doi: 10.3389/fpsyt.2023.1188101. eCollection 2023.
9
A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system.阿帕鲁胺的真实世界不均衡性分析:美国食品药品监督管理局不良事件报告系统的数据挖掘
Front Pharmacol. 2023 Jun 5;14:1101861. doi: 10.3389/fphar.2023.1101861. eCollection 2023.
10
Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.δ-8,一种源自大麻的四氢大麻酚异构体:评估美国食品药品监督管理局不良事件报告系统(FAERS)数据库中的病例报告数据。
Drug Healthc Patient Saf. 2023 Jan 29;15:25-38. doi: 10.2147/DHPS.S391857. eCollection 2023.